Published on in Vol 13 (2024)
![Evaluating the Efficacy of a Digital Therapeutic (CT-152) as an Adjunct to Antidepressant Treatment in Adults With Major Depressive Disorder: Protocol for the MIRAI Remote Study Evaluating the Efficacy of a Digital Therapeutic (CT-152) as an Adjunct to Antidepressant Treatment in Adults With Major Depressive Disorder: Protocol for the MIRAI Remote Study](https://asset.jmir.pub/assets/dd56006af7ec737b3ddd2576f25dde96.png 480w,https://asset.jmir.pub/assets/dd56006af7ec737b3ddd2576f25dde96.png 960w,https://asset.jmir.pub/assets/dd56006af7ec737b3ddd2576f25dde96.png 1920w,https://asset.jmir.pub/assets/dd56006af7ec737b3ddd2576f25dde96.png 2500w)
1 Otsuka Pharmaceutical Development & Commercialization, Inc, Princeton, NJ, United States
2 Click Therapeutics, Inc, New York, NY, United States
3 School of Medicine, Duke University, Durham, NC, United States
4 Duke-National University of Singapore Medical School, Singapore, Singapore
5 Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, United States
6 O’Donnell Brain Institute, University of Texas Southwestern Medical Center, Dallas, TX, United States
7 Otsuka Precision Health, Inc, Princeton, NJ, United States